According to our new research report “Emerging Biotech Sector in Malaysia”, Malaysia has witnessed an emergence of strong interest in biotech sector since the adoption of National Biotechnology Policy (NBP) and had properly recognized the industry as one of the key economy drivers. Driven by factors like, strong R&D base, good government support, active private sector participation, and high investments, the Malaysian biotech industry reached to the mark of US$ 180 Million in 2009 and is likely to grow at the CAGR of around 16% during 2010-2012.
Our report has found that the industrial biotech sector is likely to contribute a major share of domestic biotechnology market. In 2009, total revenue of BioNexus status companies operating in industrial biotech sector reached to the mark of US$ 111 Million, which was an increase of around 35% over 2008. The segment offers immense potential mainly due to the fact that Malaysia has a presence of large species varieties coupled with good investment patterns.
The report “Emerging Biotech Sector in Malaysia” covers all the key aspects of biotechnology industry and provides current trends and reliable statistics on each of the three segments namely agricultural biotechnology, industrial biotechnology, and healthcare biotechnology. In each of the segments, data and analysis regarding revenue, market players, patents scenario etc. have been provided. The report also covers key market attractions that seek to illustrate major growth drivers of the Malaysian biotech industry.
The report is an outcome of an in-depth research and objective analysis of the Malaysian biotech sector. It identifies and illustrates major growth drivers and trends of the industry and provides brief overview of the government role. The government has been an active player of the industry and therefore, the report describes key public sector strategies and their impact on sector performance. Future outlook till 2012 has been provided, which makes use of reliable forecasting methods and techniques. Last but not the least, key market players have also been covered in the report.
For more information visit: http://www.rncos.com/Report/IM234.htm |
